Gabrielle B Rocque1, J Nicholas Dionne-Odom2, Chao-Hui Sylvia Huang3, Soumya J Niranjan4, Courtney P Williams5, Bradford E Jackson6, Karina I Halilova4, Kelly M Kenzik5, Kerri S Bevis7, Audrey S Wallace8, Nedra Lisovicz9, Richard A Taylor2, Maria Pisu6, Edward E Partridge4, Thomas W Butler10, Linda A Briggs11, Elizabeth A Kvale12. 1. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: grocque@uabmc.edu. 2. School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama, USA. 3. Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama, USA. 4. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. 5. Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. 6. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. 7. Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. 8. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA. 9. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. 10. University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, USA. 11. Gundersen Health System, La Crosse, Wisconsin, USA. 12. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Abstract
CONTEXT: Advance care planning (ACP) improves alignment between patient preferences for life-sustaining treatment and care received at end of life (EOL). OBJECTIVES: To evaluate implementation of lay navigator-led ACP. METHODS: A convergent, parallel mixed-methods design was used to evaluate implementation of navigator-led ACP across 12 cancer centers. Data collection included 1) electronic navigation records, 2) navigator surveys (n = 45), 3) claims-based patient outcomes (n = 820), and 4) semistructured navigator interviews (n = 26). Outcomes of interest included 1) the number of ACP conversations completed, 2) navigator self-efficacy, 3) patient resource utilization, hospice use, and chemotherapy at EOL, and 4) navigator-perceived barriers and facilitators to ACP. RESULTS: From June 1, 2014 to December 31, 2015, 50 navigators completed Respecting Choices® First Steps ACP Facilitator training. Navigators approached 18% of patients (1319/8704); 481 completed; 472 in process; 366 declined. Navigators were more likely to approach African American patients than Caucasian patients (20% vs. 14%, P < 0.001). Significant increases in ACP self-efficacy were observed after training. The mean score for feeling prepared to conduct ACP conversations increased from 5.6/10 to 7.5/10 (P < 0.001). In comparison with patients declining ACP participation (n = 171), decedents in their final 30 days of life who engaged in ACP (n = 437) had fewer hospitalizations (46% vs. 56%, P = 0.02). Key facilitators of successful implementation included physician buy-in, patient readiness, and prior ACP experience; barriers included space limitations, identifying the "right" time to start conversations, and personal discomfort discussing EOL. CONCLUSION: A navigator-led ACP program was feasible and may be associated with lower rates of resource utilization near EOL.
CONTEXT: Advance care planning (ACP) improves alignment between patient preferences for life-sustaining treatment and care received at end of life (EOL). OBJECTIVES: To evaluate implementation of lay navigator-led ACP. METHODS: A convergent, parallel mixed-methods design was used to evaluate implementation of navigator-led ACP across 12 cancer centers. Data collection included 1) electronic navigation records, 2) navigator surveys (n = 45), 3) claims-based patient outcomes (n = 820), and 4) semistructured navigator interviews (n = 26). Outcomes of interest included 1) the number of ACP conversations completed, 2) navigator self-efficacy, 3) patient resource utilization, hospice use, and chemotherapy at EOL, and 4) navigator-perceived barriers and facilitators to ACP. RESULTS: From June 1, 2014 to December 31, 2015, 50 navigators completed Respecting Choices® First Steps ACP Facilitator training. Navigators approached 18% of patients (1319/8704); 481 completed; 472 in process; 366 declined. Navigators were more likely to approach African American patients than Caucasian patients (20% vs. 14%, P < 0.001). Significant increases in ACP self-efficacy were observed after training. The mean score for feeling prepared to conduct ACP conversations increased from 5.6/10 to 7.5/10 (P < 0.001). In comparison with patients declining ACP participation (n = 171), decedents in their final 30 days of life who engaged in ACP (n = 437) had fewer hospitalizations (46% vs. 56%, P = 0.02). Key facilitators of successful implementation included physician buy-in, patient readiness, and prior ACP experience; barriers included space limitations, identifying the "right" time to start conversations, and personal discomfort discussing EOL. CONCLUSION: A navigator-led ACP program was feasible and may be associated with lower rates of resource utilization near EOL.
Authors: Amber E Barnato; Denise L Anthony; Jonathan Skinner; Patricia M Gallagher; Elliott S Fisher Journal: J Gen Intern Med Date: 2009-04-23 Impact factor: 5.128
Authors: Alexi A Wright; Baohui Zhang; Alaka Ray; Jennifer W Mack; Elizabeth Trice; Tracy Balboni; Susan L Mitchell; Vicki A Jackson; Susan D Block; Paul K Maciejewski; Holly G Prigerson Journal: JAMA Date: 2008-10-08 Impact factor: 56.272
Authors: Elizabeth Trice Loggers; Paul K Maciejewski; Elizabeth Paulk; Susan DeSanto-Madeya; Matthew Nilsson; Kasisomayajula Viswanath; Alexi Anne Wright; Tracy A Balboni; Jennifer Temel; Heather Stieglitz; Susan Block; Holly G Prigerson Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544
Authors: Rajiv Agarwal; Elyse Shuk; Danielle Romano; Margaux Genoff; Yuelin Li; Eileen M O'Reilly; William Breitbart; Angelo E Volandes; Andrew S Epstein Journal: Support Care Cancer Date: 2019-06-13 Impact factor: 3.603
Authors: Yasemin Evelyn Turkman; Courtney P Williams; Bradford E Jackson; James Nicholas Dionne-Odom; Richard Taylor; Deborah Ejem; Elizabeth Kvale; Maria Pisu; Marie Bakitas; Gabrielle B Rocque Journal: J Pain Symptom Manage Date: 2019-04-11 Impact factor: 3.612
Authors: Gabrielle B Rocque; Aysha Rasool; Beverly R Williams; Audrey S Wallace; Soumya J Niranjan; Karina I Halilova; Yasemin E Turkman; Stacey A Ingram; Courtney P Williams; Andres Forero-Torres; Tom Smith; Smita Bhatia; Sara J Knight Journal: Oncologist Date: 2019-03-14
Authors: Regina M Fink; Danielle M Kline; F Amos Bailey; Daniel L Handel; Sarah R Jordan; Hillary D Lum; Stacy M Fischer Journal: J Palliat Med Date: 2020-01-16 Impact factor: 2.947
Authors: Fabian M Johnston; Joseph H Neiman; Lauren E Parmley; Alison Conca-Cheng; Karen M Freund; Thomas W Concannon; Thomas J Smith; Lisa A Cooper Journal: J Palliat Med Date: 2018-11-02 Impact factor: 2.947